Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134865) titled 'Efficacy and Safety of Tepivacaine for Postoperative Analgesia and Adverse Reactions After Robot-Assisted Radical Prostatectomy' on Oct. 21.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Weifang People's Hospital

Condition: Prostate cancer, postoperative pain, nausea and vomiting, inflammatory response

Intervention: Tepivacaine group:Intravenous patient-controlled analgesia with tepivacaine Sufentanil group:Intravenous patient-controlled analgesia with sufentanil

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-11-01

Target Sample Size: Tepivaca...